(Spoiler Alert: Key plot points of Alexander Bogdanov’s Red Star follow.)
Read More »Tag: Rick Doblin
Stalin, Clausewitz, and the Counterculture Script
From War Doctrine to Psychedelic Therapy: How Revolutionary Theory Was Dissolved into Mysticism
Read More »Doblin’s Citizens’ Diplomacy or Psychedelic Colonialism?
Just when I thought Cold War diplomacy couldn’t get weirder, Rick Doblin enters stage left with a proposal straight out of a psychedelic utopia: dose Soviet officials with MDMA to ease nuclear paranoia. Not theoretically. Literally.
Read More »What the Most Famous Book About Trauma Gets Wrong
Israeli Group to Study MDMA Therapy for October 7 Survivors With PTSD
Israeli Group to Study MDMA Therapy for October 7 Survivors With PTSD
A group of 400 Israeli survivors of the October 7 Hamas attack, including civilians, released hostages, and soldiers, could be offered MDMA-assisted psychotherapy in a potentially trailblazing study to commence later this year.
…
“Our goal is to create a therapy model that can serve universally, with the intention and prayer to help people,” said Dr. Keren Tzarfaty, CEO and co-founder of MAPS Israel, which is already running trials evaluating MDMA-assisted therapy for the treatment of post-traumatic stress disorder, depression, and eating disorders. “We hope it will demonstrate high levels of safety and effectiveness and enable us to offer the program in other places over the region and the world, not only to treat PTSD, but to help people open their hearts and expand their minds.”
…
Dr. Rick Doblin, founding president of the U.S.-based MAPS and a longtime advocate for using psychedelic therapy in the Israeli–Palestinian conflict, said that the study would serve as a seminal piece of research into whether psychedelic-assisted therapy can help large groups of traumatized people.
Read More »
Dan Crenshaw’s measure greenlighting psychedelics to treat PTSD part of defense bill + More
The legislation would allow supervised clinical studies with active-duty members.
Dan Crenshaw’s measure greenlighting psychedelics to treat PTSD part of defense bill
Related:
First-ever provision for psychedelic studies included in defense bill
National Defense Authorization Act, pp. 402-406, p. 1817 ($50,311 allocated for R&D)
FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD + More About MAPS
A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to approve MDMA as a prescription medication for the treatment of post-traumatic stress disorder (PTSD).
The MAPS Public Benefit Corporation (MAPS PBC) announced on Tuesday that it submitted the new drug application (NDA) to FDA, requesting an expedited review given that the agency previously designated the psychedelic as a breakthrough therapy.
FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD
H/T: The Most Revolutionary Act
The MAPS Public Benefit Corporation is subsidiary of Multidisciplinary Association for Psychedelic Studies. MAPS was founded by Rick Doblin.*
Related:
Read More »
Ms. Cat’s Chronicles 
You must be logged in to post a comment.